Despite the promising approval, MESO faces competition from ruxolitinib and uncertainties in pricing, market penetration, and future approvals, posing risks to the investment thesis. With ...

Nano Labs (NA) announced that it has recently increased its Bitcoin (BTC) holdings through the licensed virtual asset exchange HashKey Exchange in Hong Kong. As of December 12, the company holds a ...

After hours: December 20 at 7:24:06 PM EST Loading Chart for MESO ...

Teva Pharmaceutical Industries Ltd. ADR 3.78% $23.98B ...